TG THERAPEUTICS, INC. — Director's Dealing 2005

Mar 30, 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MANHATTAN PHARMACEUTICALS INC (MHTT)
CIK: 0001001316
Period of Report: 2005-03-29

Reporting Person: ROSENWALD LINDSAY A MD (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-03-29	Common Stock	P	4000	$1.46	Acquired	2556621	Direct
2005-03-29	Common Stock	P	1000	$1.44	Acquired	2557621	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	831213	Indirect
Common Stock	80	Indirect
Common Stock	38	Indirect
Common Stock	38	Indirect
Common Stock	33	Indirect

Footnotes

F1: Shares owned by three trusts for the benefit of the Reporting Person; however, Lester Lipshultz, and not the Reporting
Person, has voting and dispositive control over the shares owned by these three trusts. Accordingly, the Reporting Person
disclaims beneficial ownership of these shares, except as to any pecuniary interest therein.

F2: A corporation of which the Reporting Person is the sole shareholder.

F3: Does not include 2,913,058 shares of common stock and 25,524 shares of Series A Convertible Preferred Stock (which is
convertible into 232,036 shares of Common Stock), which are owned by certain trusts for the benefit of the Reporting
Person's children. The Reporting Person disclaims beneficial ownership of these shares, except to any pecuniary interest
therein. The shares owned by the trusts are reported on a separate Form 4, prepared by the trustee/investment manager.